BioNano Genomics Inc Share Price Today: Live Updates & Key Insights

BioNano Genomics Inc share price today is $1.1582, up 2.68%. The stock opened at $1.1093 against the previous close of $1.12, with an intraday high of $1.17 and low of $1.1093.

BioNano Genomics Inc Share Price Chart

BioNano Genomics Inc

us-stock
To Invest in {{usstockname}}
us-stock

BioNano Genomics Inc Share Price Performance

$1.1582 0.0268(2.68%) BNGO at 23 Mar 2026 12:16 PM Medical Instruments & Supplies
Lowest Today 1.1093
Highest Today 1.17
Today’s Open 1.1093
Prev. Close 1.12
52 Week High 5.50
52 Week Low 1.06
Day’s Range: Low 1.1093 High 1.17
52-Week Range: Low 1.06 High 5.50
1 day return -
1 Week return +2.27
1 month return +0.44
3 month return -29.02
6 month return -35.71
1 year return -65.9
3 year return -89.67
5 year return -98.75
10 year return -

BioNano Genomics Inc Institutional Holdings

GSA Capital Partners LLP 3.32

Vanguard Group Inc 0.81

Geode Capital Management, LLC 0.66

UBS Group AG 0.63

Fidelity Extended Market Index 0.51

Abante Quant Value FI 0.51

Carret & Company Inc 0.43

Vanguard Institutional Extnd Mkt Idx Tr 0.41

Two Sigma Investments LLC 0.40

Renaissance Technologies Corp 0.36

Jane Street Group LLC 0.22

NT Ext Equity Mkt Idx Fd - L 0.14

R Squared Ltd 0.14

Stifel Financial Corp 0.10

Engineers Gate Manager LP 0.10

Fidelity Series Total Market Index 0.10

BlackRock Inc 0.10

Bank of America Corp 0.08

Spartan Total Market Index Pool G 0.07

NT Ext Equity Mkt Idx Fd - NL 0.06

Morgan Stanley - Brokerage Accounts 0.06

Advisor Group Holdings, Inc. 0.06

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.05

Blackrock Extended Mkt Fund CF 0.04

Tower Research Capital LLC 0.03

PGIM US Micro Cap Quant Equity 0.03

Extended Equity Market Fund K 0.03

Fidelity Total Market Index 0.03

Group One Trading, LP 0.01

Northern Trust Extended Eq Market Idx 0.01

T. Rowe Price U.S. Equities Tr 0.01

Concord Wealth Partners 0.01

Extended Equity Market Fund M 0.00

SBI Securities Co Ltd 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Spartan Extended Market Index Pool F 0.00

Vanguard U.S. Eq Idx £ Acc 0.00

Wells Fargo & Co 0.00

SSgA U.S. Total Market Index Strategy 0.00

BioNano Genomics Inc Market Status

Strong Buy: 0

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

BioNano Genomics Inc Fundamentals

Market Cap 11.13 M

PB Ratio 0.2309

PE Ratio 0.0

Enterprise Value 7.11 M

Total Assets 76.67 M

Volume 395607

BioNano Genomics Inc Company Financials

Annual Revenue FY23:33610000 33.6M, FY22:27802000 27.8M, FY21:17981000 18.0M, FY20:8502984 8.5M, FY19:10129508 10.1M

Annual Profit FY23:8933000 8.9M, FY22:5945000 5.9M, FY21:3874000 3.9M, FY20:2772847 2.8M, FY19:3361361 3.4M

Annual Net worth FY23:-227279000 -227.3M, FY22:-132596000 -132.6M, FY21:-72435000 -72.4M, FY20:-41135544 -41.1M, FY19:-29836118 -29.8M

Quarterly Revenue Q3/2025:7367000 7.4M, Q2/2025:6733000 6.7M, Q1/2025:6457000 6.5M, Q3/2024:6073000 6.1M, Q2/2024:7771000 7.8M

Quarterly Profit Q3/2025:3525000 3.5M, Q2/2025:3477000 3.5M, Q1/2025:2938000 2.9M, Q3/2024:-8446000 -8.4M, Q2/2024:2585000 2.6M

Quarterly Net worth Q3/2025:-8503000 -8.5M, Q2/2025:-6857000 -6.9M, Q1/2025:-3102000 -3.1M, Q3/2024:-44246000 -44.2M, Q2/2024:-16224000 -16.2M

About BioNano Genomics Inc & investment objective

Company Information Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA; and Ionic purification system, which isolates and purifies nucleic acid molecules. In addition, the company offers Saphyr, Stratys, and Bionano compute servers; and VIA software, which offers one solution for analysis and interpretation of genomic data from microarray and sequencing data for cytogenetics and molecular genetics. Further, it provides testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Organisation Medical Instruments & Supplies

Employees 98

Industry Medical Instruments & Supplies

CEO Dr. Robert Erik Holmlin M.B.A., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BioNano Genomics Inc FAQs

What is the share price of BioNano Genomics Inc today?

The current share price of BioNano Genomics Inc is $1.1582.

Can I buy BioNano Genomics Inc shares in India?

Yes, Indian investors can buy BioNano Genomics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy BioNano Genomics Inc shares in India?

You can easily invest in BioNano Genomics Inc shares from India by:

Can I buy fractional shares of BioNano Genomics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BioNano Genomics Inc?

BioNano Genomics Inc has a market cap of $11.13 M.

In which sector does BioNano Genomics Inc belong?

BioNano Genomics Inc operates in the Medical Instruments & Supplies sector.

What documents are required to invest in BioNano Genomics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of BioNano Genomics Inc?

The PE ratio of BioNano Genomics Inc is N/A and the PB ratio is 0.23.